Cambridge Investment Research Advisors »

Humacyte shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $41k 24k 1.73
2025-06-30 $60k 29k 2.08
2025-03-31 $24k 14k 1.72
2024-12-31 $79k 16k 5.04
2024-09-30 $72k 13k 5.41
2024-06-30 $53k 11k 4.81

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
Susquehanna International
Morgan Stanley
Two Sigma Investments
Millennium Management
Citadel Advisors
Northern Trust
Private Advisor
Charles Schwab Investment Management
Marshall Wace

View all funds holding Humacyte